Roche, Hetero donate antiflu meds in India; Sanofi nabs Canadian OK for Multaq;

> Roche's Indian unit and India's Hetero Drugs together donated 100,000 doses of Tamiflu/oseltamivir to the Indian government as the H1N1 flu spreads in the country. Report

> Sanofi-Aventis won Canadian approval for its atrial fibrillation remedy Multaq, the only new treatment for managing the condition in 20 years. Release

> The federal agency that manages Medicare said most beneficiaries would see a small increase in their drug-plan premiums next year. Report

> A CDC study found that more than twice as many children are accidentally poisoned with prescription or over-the-counter medicines as with household consumer products. Report

> Discovery Laboratories said that CEO Robert Capetola has resigned and will be replaced on an interim basis by Chairman W. Thomas Amick. Report

Biotech News

> Shares of BioSante Pharmaceuticals shot up 69 percent in pre-market trading after the developer announced positive late-stage safety data for its female dysfunction treatment LibiGel. Report

> Score one for Wisconsin's biotech economic development team. Dangling close to a million dollars in new investment capital and a loan, the state hooked the Boston-based biotech Flex Biomedical, which will now move from the big biotech hub in Bean Town to Madison. Report

> The Biotechnology Industry Organization and Thomson Reuters stuck their fingers into the market air and detected distinct signs of a growing wind filling the sails of the nation's biotech industry. Report

> The fast-growing Cambridge, MA-based Constellation Pharmaceuticals has a new CEO and a fresh injection of cash to fund its work in the field of epigenetics. The company has named Mark A. Goldsmith, M.D., Ph.D., to the top post and closed on $17 million in fresh venture funds, the third tranche of its Series A. Report

And Finally... Scientists said they have found a drug compound that attacks in a new way the stem cells that fuel tumor growth, opening a path to a new type of anti-cancer treatment. Report

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.